FDA launches pilot programme to track and trace US supply chain
The pilot project will test innovative and emerging approaches for enhanced tracing and verification of prescription drugs in the US...
List view / Grid view
The pilot project will test innovative and emerging approaches for enhanced tracing and verification of prescription drugs in the US...
Service expansion in Brazil will meet transportation demands of the pharmaceutical and clinical research industry...
The pharma corridor between Hong Kong and Brussels Airport assures handling quality for temperature-sensitive pharmaceuticals.
On 23 June 2016, the decision was made on the European Union referendum for the United Kingdom to withdraw from the European Union.
A market report on the aspirin enteric-coated pharmaceutical industry outlines current trends and opportunities for growth from 2018 until 2023...
A study has found that an alarming number of families share leftover antibiotics between siblings, parents and others not even related to the family...
29 October 2018 | By Charles River
Timelines, budgets and regulatory constraints have grown alongside that of the Quality Control (QC) lab’s position in drug development. The main goal of the lab and more widely of the manufacturing industry is to increase safety for the end user and guarantee patients’ health...
The next five years will see game-changing improvements made in upstream, downstream and continuous bioprocessing, predicts one industry specialist...
18 September 2018 | By Clarivate Analytics
In 2017 the WHO estimated that the counterfeit drug market represents around 10-15 percent of the pharmaceutical market worldwide, with an estimated $200bn revenue per year. Worldwide there were 3,509 pharmaceutical crime incidents in 2017, which represents an 11% increase from 2016. Most falsified medicines that reach the market do…
The FDA is seeking closer collaboration with state authorities to ensure the quality of compounded drugs and the public’s access to them...
As the UK prepares to withdraw from the EU on 29th March 2019 at 23:00, this article delivers a US perspective on what Brexit is likely to mean for pharmaceutical companies.
Improving data integrity is the aim of a new guide published by the Russian State Institute for Drugs and Good Practices in collaboration with consultancy PQE Group...
A new project led by the Karolinska Institutet in Sweden aims to improve the standards of drug safety in East Africa...
A Europe-wide policy covering the generic pharmaceuticals market would significantly boost growth in the sector, reveals a new report from Frost & Sullivan...
Novartis announced that the European Commission approved ribociclib in combination with an aromatase inhibitor for treatment of postmenopausal women with metastatic breast cancer